Literature DB >> 21136874

Identification of proteins in human substantia nigra.

Efstathia Kitsou1, Sheng Pan, Jianpeng Zhang, Min Shi, Aram Zabeti, Dennis W Dickson, Roger Albin, Marla Gearing, Daniel T Kashima, Yan Wang, Richard P Beyer, Yong Zhou, Catherine Pan, W Michael Caudle, Jing Zhang.   

Abstract

Characterization of the human brain proteome is a critical area of research. While examination of the human cortex has provided some insight, very little is known about the proteome of the human midbrain, which demonstrates substantial loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) in Parkinson's disease (PD). Therefore, characterization of this region is essential to a better understanding of the pathogenesis of PD. This dataset paper reports two separate studies, where human SNpc was collected from PD and control subjects and 1263 proteins were identified using MALDI-TOF/TOF as well as linear ion trap MS platforms. With gene ontology analysis, the proteins were categorized according to their biological processes, as well as cellular components. These data were also compared with previous proteomic characterization of the human frontal and temporal cortex, and cerebrospinal fluid to establish shared proteins of relevance. The present dataset is the most extensive survey of the human SNpc proteome, to date. Further characterization of the SNpc proteome will significantly facilitate our understanding of the function and expression of proteins involved in PD, as well as provide potential proteins that may be utilized as biomarkers.
Copyright © 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2008        PMID: 21136874     DOI: 10.1002/prca.200800028

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  16 in total

Review 1.  Biomarkers for cognitive impairment in Parkinson disease.

Authors:  Min Shi; Bertrand R Huber; Jing Zhang
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  Enrichment of single neurons and defined brain regions from human brain tissue samples for subsequent proteome analysis.

Authors:  Mariana Molina; Simone Steinbach; Young Mok Park; Su Yeong Yun; Ana Tereza Di Lorenzo Alho; Helmut Heinsen; Lea T Grinberg; Katrin Marcus; Renata E Paraizo Leite; Caroline May
Journal:  J Neural Transm (Vienna)       Date:  2015-06-30       Impact factor: 3.575

Review 3.  Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.

Authors:  Eugene M Cilento; Lorrain Jin; Tessandra Stewart; Min Shi; Lifu Sheng; Jing Zhang
Journal:  J Neurochem       Date:  2019-01-31       Impact factor: 5.372

Review 4.  Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Authors:  Anubhuti Dixit; Rachna Mehta; Abhishek Kumar Singh
Journal:  Cell Mol Neurobiol       Date:  2019-06-12       Impact factor: 5.046

5.  Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.

Authors:  W Michael Caudle; Sheng Pan; Min Shi; Thomas Quinn; Jake Hoekstra; Richard P Beyer; Thomas J Montine; Jing Zhang
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

6.  Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.

Authors:  Min Shi; James Movius; Romel Dator; Patrick Aro; Yanchun Zhao; Catherine Pan; Xiangmin Lin; Theo K Bammler; Tessandra Stewart; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; Jing Zhang
Journal:  Mol Cell Proteomics       Date:  2015-01-02       Impact factor: 5.911

Review 7.  Glycoproteomics in neurodegenerative diseases.

Authors:  Hyejin Hwang; Jianpeng Zhang; Kathryn A Chung; James B Leverenz; Cyrus P Zabetian; Elaine R Peskind; Joseph Jankovic; Zhen Su; Aneeka M Hancock; Catherine Pan; Thomas J Montine; Sheng Pan; John Nutt; Roger Albin; Marla Gearing; Richard P Beyer; Min Shi; Jing Zhang
Journal:  Mass Spectrom Rev       Date:  2010 Jan-Feb       Impact factor: 10.946

8.  A role for a novel protein, nucleolin, in Parkinson's disease.

Authors:  W Michael Caudle; Efstathia Kitsou; Jane Li; Joshua Bradner; Jing Zhang
Journal:  Neurosci Lett       Date:  2009-05-04       Impact factor: 3.046

Review 9.  Biomarker discovery in neurodegenerative diseases: a proteomic approach.

Authors:  Min Shi; W Michael Caudle; Jing Zhang
Journal:  Neurobiol Dis       Date:  2008-09-26       Impact factor: 5.996

Review 10.  Emerging candidate biomarkers for Parkinson's disease: a review.

Authors:  Enrico Saracchi; Silvia Fermi; Laura Brighina
Journal:  Aging Dis       Date:  2013-10-09       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.